Rocket


News + Filings
Transactions



Harrison Seth Loring

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/13/2023Stoke Therapeutics, Inc.STOKGrantDirector Stock Option (Right to Buy)19.4k$12.46$242.2k 06/13/2023
11/30/2022Akero Therapeutics, Inc.AKROSaleCommon Stock6.3k$46.44$293.6k 11/30/2022
11/30/2022Akero Therapeutics, Inc.AKROSaleCommon Stock4.8k$47.60$227.5k 11/30/2022
11/30/2022Akero Therapeutics, Inc.AKROSaleCommon Stock6.9k$46.44$318.1kSee Footnote11/30/2022
11/30/2022Akero Therapeutics, Inc.AKROSaleCommon Stock5.2k$47.60$246.5kSee Footnote11/30/2022
10/28/2022Akero Therapeutics, Inc.AKROSaleCommon Stock20.3k$40.28$819.2k 10/28/2022
10/28/2022Akero Therapeutics, Inc.AKROSaleCommon Stock800$41.12$32.9k 10/28/2022
10/28/2022Akero Therapeutics, Inc.AKROSaleCommon Stock22.1k$40.28$890kSee Footnote10/28/2022
10/28/2022Akero Therapeutics, Inc.AKROSaleCommon Stock869$41.12$35.7kSee Footnote10/28/2022
10/27/2022Akero Therapeutics, Inc.AKROSaleCommon Stock4k$43.23$173.5kSee Footnote10/25/2022
10/27/2022Akero Therapeutics, Inc.AKROSaleCommon Stock23.7k$42.03$996.9kSee Footnote10/25/2022
10/27/2022Akero Therapeutics, Inc.AKROSaleCommon Stock44.4k$41.12$1.8MSee Footnote10/25/2022
10/27/2022Akero Therapeutics, Inc.AKROSaleCommon Stock3.7k$43.23$159.7k 10/25/2022
10/27/2022Akero Therapeutics, Inc.AKROSaleCommon Stock21.8k$42.03$917.5k 10/25/2022
10/27/2022Akero Therapeutics, Inc.AKROSaleCommon Stock40.9k$41.12$1.7M 10/25/2022
10/26/2022Akero Therapeutics, Inc.AKROSaleCommon Stock20.1k$44.90$901.8kSee Footnote10/25/2022
10/26/2022Akero Therapeutics, Inc.AKROSaleCommon Stock12.5k$43.97$551.3kSee Footnote10/25/2022
10/26/2022Akero Therapeutics, Inc.AKROSaleCommon Stock39k$43.08$1.7MSee Footnote10/25/2022
10/26/2022Akero Therapeutics, Inc.AKROSaleCommon Stock18.5k$44.90$830k 10/25/2022
10/26/2022Akero Therapeutics, Inc.AKROSaleCommon Stock11.5k$43.97$507.4k 10/25/2022
10/26/2022Akero Therapeutics, Inc.AKROSaleCommon Stock35.9k$43.08$1.5M 10/25/2022
10/25/2022Akero Therapeutics, Inc.AKROSaleCommon Stock4.9k$44.92$220.4kSee Footnote10/25/2022
10/25/2022Akero Therapeutics, Inc.AKROSaleCommon Stock4.5k$44.92$202.8k 10/25/2022
06/07/2022Stoke Therapeutics, Inc.STOKGrantDirector Stock Option (Right to Buy)21k$12.96$272.2k 06/07/2022
06/02/2022Akero Therapeutics, Inc.AKROGrantStock Option (Right to Buy)15k$8.13$122k 06/02/2022
06/08/2021Stoke Therapeutics, Inc.STOKGrantDirector Stock Option (Right to Buy)11.6k$40.37$470.3k 06/08/2021
06/01/2021Akero Therapeutics, Inc.AKROGrantStock Option (Right to Buy)13k$26.32$342.2k 06/01/2021
11/24/2020Stoke Therapeutics, Inc.STOKPurchaseCommon Stock375k$39.00$14.6MBy Apple Tree Partners IV, L.P.11/24/2020
07/10/2020Akero Therapeutics, Inc.AKROPurchaseCommon Stock415k$36.00$14.9MSee Footnote07/10/2020
06/03/2020Stoke Therapeutics, Inc.STOKGrantDirector Stock Option (Right to Buy)14.8k$26.53$392k 06/03/2020
06/01/2020Akero Therapeutics, Inc.AKROGrantStock Option (Right to Buy)13k$25.20$327.6k 06/01/2020
11/08/2019Akero Therapeutics, Inc.AKROGrantStock Option (Right to Buy)26k$19.97$519.2k 11/08/2019
09/10/2019Stoke Therapeutics, Inc.STOKGrantDirector Stock Option (Right to Buy)29.6k$28.80$851.2k 09/10/2019
06/24/2019Akero Therapeutics, Inc.AKROConversionCommon Stock4.2M$0.00$0See Footnote06/24/2019
06/24/2019Akero Therapeutics, Inc.AKROConversionCommon Stock286.4k$0.00$0See Footnote06/24/2019
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy